Article Details

Avidity Announces First Person Dosed with an Antibody Oligonucleotide Conjugate (AOC™)

Retrieved on: 2021-11-04 13:08:57

Tags for this article:

Click the tags to see associated articles and topics

Avidity Announces First Person Dosed with an Antibody Oligonucleotide Conjugate (AOC™). View article details on hiswai:

Excerpt

AOCs are designed to combine the proven technology of monoclonal antibodies with the precision and potency of oligonucleotide therapies to access ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up